APA (7th ed.) Citation

RB, C., J, R., KC, K., S, W., A, C., & H, W. (2004). Rosiglitazone for HIV-1 lipoatrophy. Lancet, 363(9423), 1828. https://doi.org/10.1016/s0140-6736(04)16318-6

Chicago Style (17th ed.) Citation

RB, Cavalcanti, Raboud J, Kain KC, Walmsley S, Carr A, and Wand H. "Rosiglitazone for HIV-1 Lipoatrophy." Lancet 363, no. 9423 (2004): 1828. https://doi.org/10.1016/s0140-6736(04)16318-6.

MLA (9th ed.) Citation

RB, Cavalcanti, et al. "Rosiglitazone for HIV-1 Lipoatrophy." Lancet, vol. 363, no. 9423, 2004, p. 1828, https://doi.org/10.1016/s0140-6736(04)16318-6.